Humans

Ferguson, L. D., Molenberghs, G., Verbeke, G., Rahimi, K., Rao, S., McInnes, I. B., et al. (2024). Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol, 6, e156-e167. http://doi.org/10.1016/s2665-9913(23)00338-7
View
Yang, J., Andersen, K. M., Rai, K. K., Tritton, T., Mugwagwa, T., Tsang, C., et al. (2024). Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study. Pediatr Infect Dis J, 43, 209-216. http://doi.org/10.1097/inf.0000000000004213
View
Abhishek, A., Grainge, M., Card, T., Williams, H. C., Taal, M. W., Aithal, G. P., et al. (2024). Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. Rmd Open, 10. http://doi.org/10.1136/rmdopen-2023-003980
View
Czira, A., Banks, V., Requena, G., Wood, R., Tritton, T., Wild, R., et al. (2024). Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. Bmj Open, 14, e072361. http://doi.org/10.1136/bmjopen-2023-072361
View
Robinson, J. W., Martin, R., Ozawa, M., Elwenspoek, M. M. C., Redaniel, M. T., Kurian, K., & Ben-Shlomo, Y. (2024). Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD). Bmj Open, 14, e072026. http://doi.org/10.1136/bmjopen-2023-072026
View
Masarwa, R., Reynier, P., Lefebvre, C., Platt, R. W., Delaney, J. A. C., & Filion, K. B. (2024). Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment. Pharmacoepidemiol Drug Saf, 33, e5752. http://doi.org/10.1002/pds.5752
View
Lee, C., Rizzi, S., Bierrenbach, A. L., Antunes, L., Nissinen, N. M., Rocha, O., et al. (2024). Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register. Pharmacoepidemiol Drug Saf, 33, e5761. http://doi.org/10.1002/pds.5761
View
Gunathilaka, N. J., Gooden, T. E., Cooper, J., Flanagan, S., Marshall, T., Haroon, S., et al. (2024). Perceptions on artificial intelligence-based decision-making for coexisting multiple long-term health conditions: protocol for a qualitative study with patients and healthcare professionals. Bmj Open, 14, e077156. http://doi.org/10.1136/bmjopen-2023-077156
View
Guthrie, B., Rogers, G., Livingstone, S., Morales, D. R., Donnan, P., Davis, S., et al. (2024). The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health Soc Care Deliv Res, 12, 1-275. http://doi.org/10.3310/kltr7714
View
Dedman, D., Williams, R., Bhaskaran, K., & Douglas, I. J. (2024). Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases. Bmj Open, 14, e070258. http://doi.org/10.1136/bmjopen-2022-070258
View